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Juvenile myoclonic epilepsy (JME) is often exquisitely responsive to treatment with valproic acid (VPA). However, a subset of
patients does not respond to this medication and often has intractable seizures. We wanted to identify differences between these
two subsets of JME patients.
Charts of all JME patients followed at the Duke Epilepsy Center were reviewed. Clinical parameters, electroencephalo-
gram (EEG) findings and magnetic resonance imaging (MRI) data were reviewed. These features were compared between
patients with VPA sensitive and VPA resistant JME.
Thirty-three patients with JME were identified: 23 (70%) were VPA sensitive (13 females, 10 males; mean age of onset
15.9 years) and 10 (30%) were VPA resistant (5 females, 5 males; mean age of onset 14.1 years). The VPA resistant group had a
higher frequency of EEG asymmetries (40% vs. 10%); atypical seizure characteristics including auras and post-ictal confusion
(30% vs. 4%); and intellectual deficiency (20% vs. 0%).
Clinical characteristics combined with EEG data may help in predicting which JME patients will respond favorably to VPA.
This study also raises the issue whether VPA resistant JME is in fact a localization-related epilepsy.
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INTRODUCTION
Juvenile myoclonic epilepsy (JME) is a common type
of epilepsy, representing 26% of idiopathic general-
ized epilepsies1. It typically presents in adolescence
with myoclonic seizures with or without absence
and generalized tonic–clonic seizures (GTCS). Bi-
lateral and synchronous 4–6/second polyspike and
wave complexes characterize the electroencephalo-
gram (EEG) in most patients. Most patients respond
to valproic acid (VPA) monotherapy, with excellent
seizure control achieved in as high as 82–97% of
patients2–5. There is a subset of patients, however,
whose seizures do not respond to VPA. This study
was undertaken to determine whether there were any
differences between these two subgroups of JME
patients.
MATERIALS AND METHODS
Charts of all patients with JME followed at the Duke
Epilepsy Center were reviewed. Demographic data in-
cluding sex, age at seizure onset, time to diagnosis of
JME, seizure types and characteristics, family history
of seizures and assessment of mental functioning were
reviewed. VPA responsive patients were defined as
those who were seizure free on VPA monotherapy. In-
cluded in this group were patients with occasional my-
oclonus that did not interfere with functioning as well
those with breakthrough seizures secondary to non-
compliance. VPA resistance was defined as recurrent
seizures despite therapeutic levels (50–100 mg dl−1)
of VPA. Age at seizure onset was defined as the age at
which the first seizure was noted, whether myoclonic,
absence or generalized tonic–clonic. The time to diag-
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nosis was defined as the number of years from seizure
onset to time diagnosis and/or appropriate therapy, i.e.
VPA was instituted, whichever came first.
Unusual seizure characteristics and history were
noted. These included previous history of febrile
seizures, presence of auras and post-ictal confusion
following absence and myoclonic seizures. Addition-
ally, features of focal seizures, i.e. Todd’s paralysis,
focal motor activity, aphasia, etc., were noted.
Family history of seizures was determined. As most
patients were unfamiliar with the type and etiology of
seizures in the family members, all relatives with any
type of seizure disorder were included.
Mental functioning was assessed based on exam-
iner’s mental status examination, school performance
(whether patient required special education) and intel-
ligence quotient (IQ) scores when available. Intellec-
tual deficiency was defined as IQ scores less than 80,
need for special education classes or mini-mental sta-
tus scores less than 23.
All EEGs in the VPA resistant group and 81% of
the EEGs in the VPA sensitive group were performed
at the Duke Epilepsy Center and examined for asym-
metries by board-certified electroencephalographers.
EEG asymmetry was defined as the presence of con-
sistently unilateral epileptiform discharges indepen-
dent of the generalized epileptiform activity, focal
slowing, and persistent unilateral predominance of bi-
lateral, synchronous polyspike and wave discharges.
All magnetic resonance imaging (MRI) reports were
reviewed for presence of lesions and other abnormali-
ties.
RESULTS
Thirty-seven patients with JME were identified; two
patients with well-controlled JME were excluded
since neither had been tried on VPA. The first was
unable to afford valproate hence was on lamotrigine
through a drug assistance program. The second was a
woman of childbearing age who planned to become
pregnant and was well controlled on mysoline. Two
patients with medically intractable JME were also ex-
cluded as both had only very brief trials of VPA and
were unable to reach therapeutic levels due to in-
tolerable gastrointestinal side-effects. Of the remain-
ing 33 patients, 23 (70%) were VPA responsive and
10 (30%) were VPA resistant. The summary of results
is shown in Table 1.
Sex
Eighteen females (55%) and 15 (45%) males with
JME were identified. There were 10 (43%) males and
13 females (57%) in the VPA sensitive group and
5 (50%) males and 5 (50%) females in the VPA re-
sistant subgroup.
Table 1: Clinical characteristics of VPA sensitive vs. VPA re-
sistant JME patients.
VPA sensitive JME VPA resistant JME
n = 23 (70%) n = 10 (30%)
Sex: Male 10 (43) 5 (50)
Female 13 (57) 5 (50)
Mean age at seizure 15.9 14.1
onset (years)
Mean time to diagnosis 8.9 11.6
of JME (years)
Family history of seizures 7 (30) 3 (30)
Atypical seizure 1 (4) 3 (30)
characteristics
Intellectual deficiency 0 (0) 2 (20)
EEG asymmetries 2/21 (10) 4/10 (40)
MRI abnormalities 1/5 (20) 2/9 (22)
VPA = valproic acid, JME = juvenile myoclonic epilepsy, EEE =
electroencephalogram, MRI = magnetic resonance imaging.
Age at seizure onset
Patients in the VPA sensitive group tend to have later
onset of seizures, mean age of 15.91 years, median
16 years vs. the VPA resistant group who had mean
seizure onset 2 years earlier at 14 years (median
14 years). Statistical analysis between the two groups
could not be performed due to the small number of
patients.
Time to diagnosis/treatment of JME
The number of years prior to correct diagnosis and
treatment of JME was delayed in most patients to an
average of 9.73 years with greater than 2.5 years dif-
ference between the two subgroups of patients. The
VPA sensitive group were diagnosed and treated ear-
lier with a mean time to diagnosis of 8.91 years (range
of 0–52 years, median 3 years) whereas the VPA resis-
tant group were diagnosed and treated at a mean age
of 11.60 years (range of 0–28 years, median 7 years).
Family history of seizures
Ten (30%) JME patients had family history of
seizures. This was identified in 7 of the 25 (30%) VPA
sensitive patients and in 3 of the 10 (30%) VPA resis-
tant patients.
Atypical seizure characteristics
One patient (4%) with VPA sensitive JME reported
an aura of a strange cephalic sensation occurring sec-
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onds to minutes prior to a GTCS. Three (30%) patients
in the VPA resistant group had atypical seizure his-
tory. One patient reported post-ictal confusion follow-
ing a series of myoclonic jerks and a second patient de-
scribed similar confusion following absence seizures.
The third patient had history of one febrile and one
afebrile seizure at 2.5 years of age.
Intellectual functioning
All patients with VPA sensitive JME had clini-
cally normal intelligence as assessed by examina-
tion, school performance and daily functioning. Two
patients (20%) in the VPA resistant group had intellec-
tual deficiency with full-scale IQ scores of 64 and 78.
EEG asymmetries
Twenty-one (91%) patients with VPA sensitive JME
and all patients with VPA resistant JME had EEGs,
87% of which were done at the Duke Epilepsy Cen-
ter and were available for review. Among patients in
the VPA sensitive group, 2 (10%) had EEGs with fo-
cal abnormalities. One patient had occasional right
frontotemporal sharp waves. The second patient had
left temporal slowing. The latter patient had a closed
head injury at 20 years of age (6 years after the on-
set of JME) with residual mild right hemiparesis. If
this patient was excluded, only 1 patient (5%) would
have had focal EEG abnormalities in the VPA sensi-
tive group.
Among patients in the VPA resistant group, 4 (40%)
had focal EEG abnormalities. The focal abnormalities
seen in this group were left frontal amplitude predom-
inance of generalized 1.5–6 Hz generalized polyspike
and wave discharges; intermittent left temporal slow-
ing; occasional right frontal epileptiform discharges;
and left frontotemporal slowing with hyperventilation
seen in one patient each.
MRI abnormalities
Five of the VPA sensitive patients had MRIs, 4 of
which were normal and 1 (20%) had a smaller left tem-
poral lobe. Nine patients in the VPA resistant group
had MRIs, 7 (78%) of which were normal and 2 (22%)
had smaller left hippocampus without accompanying
signal abnormalities.
DISCUSSION
VPA is the drug of choice for JME with excellent
seizure control achieved in 82–97% of JME patients.
In this study 30% of the patients were VPA resistant,
probably reflecting the higher incidence of medically
intractable seizures seen at epilepsy centers. There
were no remarkable differences in sex, age of onset,
family history of seizures and incidence of MRI abnor-
malities between the VPA sensitive and resistant JME
subgroups.
Studies have identified JME as one of the more
common types of epilepsy, accounting for 5–10%
of all epilepsies6–9. Though common, JME is often
missed and appropriate treatment frequently delayed.
Grunewald et al.10 reported a mean delay in diagnosis
of 14.5 years. Delay in diagnosis often occurs due to
lack of familiarity with the syndrome, failure to elicit
a history of myoclonic jerks and high prevalence of fo-
cal abnormalities on EEG. The shorter time to diagno-
sis seen in our patients probably represents improved
awareness of the syndrome at referral centers. Diagno-
sis was delayed even more in patients with VPA resis-
tant JME. This is likely due to a higher incidence of
asymmetric EEG abnormalities, unusual seizure char-
acteristics and intellectual deficiency as noted in the
VPA resistant subgroup of this study. These findings
may mislead physicians to diagnose a localization-
related epilepsy in these patients.
As JME is an idiopathic generalized epilepsy, fo-
cal features such as aura and post-ictal Todd’s paral-
ysis are not expected. However a number of stud-
ies have noted focal seizure characteristics in JME
patients11, 12. Absence seizures in JME are usually of
the simple type with rapid return to normal mental sta-
tus. Panayiotopoulos et al.13, however, have described
atypical absence seizures in one patient with JME.
A higher incidence of febrile seizure (4.4–10%) has
been documented in JME as well1, 4 compared to the
overall incidence of 2–5%14, 15. This study had sim-
ilar findings. One patient in the VPA sensitive group
had a cephalic sensation prior to GTCS; this finding
however can often be seen with GTCS. One patient in
the VPA resistant group had post-ictal confusion fol-
lowing absence seizures and another had similar con-
fusion following myoclonic seizures. Another patient
in the VPA resistant group had febrile and afebrile
seizures at age 2.5 years.
In this study, atypical seizure characteristics were
more frequently seen in the VPA resistant group (33%
vs. 14%). This raises the issue of whether the VPA re-
sistant JME group is in fact a refractory localization-
related epilepsy. This may in part explain the resis-
tance to VPA in these patients as VPA, despite be-
ing an anticonvulsant with broad spectrum activity, is
more effective in primary generalized epilepsy16.
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Patients with JME have a normal neurologic exam-
ination17. In this study, one VPA sensitive patient ex-
hibited mild right hemiparesis and left temporal slow-
ing on EEG following a closed head injury. The head
injury, which was presumably the cause of the focal
slowing, was sustained 6 years after onset of seizures.
The rest of the VPA sensitive patients had normal neu-
rologic examinations. Two (20%) patients in the VPA
resistant group had IQ scores less than 80, indicating
diffuse neuronal dysfunction, raising the suspicion that
these patients may have a different form of epilepsy,
i.e. a localization-related or symptomatic generalized
epilepsy.
Bilateral and synchronous 4–6/second polyspike
and wave discharges characterize the EEGs of patients
with JME. EEG asymmetries, however, are not un-
common in JME17–19. Aliberti et al.18 found am-
plitude asymmetries in the generalized discharges in
72.7% and focal abnormalities in 54.5% of JME
patients. Lancman et al.19 noted EEG asymmetries
in 16% of their JME patients. These studies included
shifting EEG asymmetries. In this study, focal abnor-
malities were seen in 40% of the VPA resistant group
and only in 10% of the VPA sensitive group. These
findings suggest that patients with VPA resistant JME
have higher incidence of focal EEG abnormalities,
suggestive of a partial epilepsy.
Neuroimaging abnormalities have not been demon-
strated in JME patients20. In this study one (20%)
of the 5 patients with VPA resistant JME who had
MRIs had a smaller left temporal lobe though the
hippocampi looked symmetric. The significance of
this finding was questionable. However 2 (22%) VPA
resistant patients had asymmetric hippocampal sizes
without signal abnormalities. These focal MRI find-
ings also suggest the possibility of localization-related
epilepsy in these patients.
The findings of this study are consistent with
Dasheiff and Ritaccio’s21 report of 12 patients with
medically intractable JME who had higher incidence
of asymmetric EEG abnormalities as well as longer
duration of seizures with delay in diagnosis and treat-
ment. In addition to these factors, neurologic abnor-
malities as well as atypical seizure characteristics and
history also appear to be more common in patients
with VPA resistant JME.
This study suggests that there are two relatively
distinct JME subgroups. The clinical characteristics
of the VPA sensitive group resemble the typical
JME syndrome described by Janz22. The VPA resis-
tant group, however, has a higher incidence of atyp-
ical characteristics including asymmetric EEG ab-
normalities, atypical seizure characteristics and his-
tory, and neurological and neuroimaging abnormali-
ties. The presence of these characteristics may help
predict which patients will respond to VPA and which
ones would require different or additional medica-
tions. Whether the VPA resistant subgroup represents
atypical JME or a different type of epilepsy (i.e. local-
ization related) remains to be determined.
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